Coexistence of AML1/RUNX1 and BCR-ABL Point Mutations in an Imatinib-Resistant Form of CML

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403931
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC